ZVSA - ZyVersa Therapeutics Inc
0.3113
-0.238 -76.357%
Share volume: 12,453,600
Last Updated: 07-16-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.20%
PREVIOUS CLOSE
CHG
CHG%
$0.55
-0.24
-0.43%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-09-2024 | 11-14-2024 | 03-27-2025 | 05-12-2025 | 11-19-2025 | |
| Assets | |||||||
| Total Assets | 21.651 M | 19.470 M | 19.424 M | 20.599 M | 20.986 M | 1.040 M | |
| Current Assets | 2.900 M | 641.392 K | 390.415 K | 1.716 M | 2.110 M | 995.533 K | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 169.363 K | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 2.034 M | 119.486 K | 122.921 K | 1.531 M | 1.612 M | 527.978 K | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 4.333 K | 1.733 K | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Assets | 18.648 M | 18.826 M | 18.855 M | 18.884 M | 18.875 M | 44.727 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 21.651 M | 19.470 M | 19.424 M | 20.599 M | 20.986 M | 1.040 M | |
| Total liabilities | 10.428 M | 10.849 M | 12.397 M | 12.083 M | 12.855 M | 12.766 M | |
| Total current liabilities | 9.583 M | 9.995 M | 11.542 M | 11.231 M | 12.004 M | 12.766 M | |
| Accounts Payable | 8.128 M | 8.317 M | 9.285 M | 9.337 M | 9.605 M | 9.805 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 11.223 M | 8.620 M | 7.027 M | 8.516 M | 8.130 M | -11.726 M | |
| Common stock | 117.276 M | 117.437 M | 118.245 M | 121.156 M | 123.027 M | 125.188 M | |
| Retained earnings | -106.046 M | -108.810 M | -111.211 M | -112.633 M | -114.889 M | -136.906 M |